Stem cell therapy for ischemic heart disease

Translational Approach to Heart Failure

Volumn , Issue , 2013, Pages 449-465

  Behfar, Atta ^a   Bartunek, Jozef ^b   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

^b CARDIOVASCULAR CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956633775     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-7345-9_18     Document Type: Chapter

References (80)

1. Terzic A, Waldman SA (2011) Chronic diseases: the emerging pandemic. Clin Transl Sci 4:225-226
2. Roger VL et al (2012) Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 125:188-197
3. Kovacic JC, Castellano JM, Fuster V (2012) Cardiovascular defense challenges at the basic, clinical, and population levels. Ann N Y Acad Sci 1254:1-6
4. Terzic A, Nelson TJ (2010) Regenerative medicine advancing health care 2020. J Am Coll Cardiol 55:2254-2257
5. Terzic A, Folmes CD, Martinez-Fernandez A, Behfar A (2011) Regenerative medicine: on the vanguard of health care. Mayo Clin Proc 86:600-602
6. 3regenerative medicine paradigm. Clin Transl Sci 1:168-171
7. Terzic A, Edwards BS, McKee KC, Nelson TJ (2011) Regenerative medicine: a reality of stem cell technology. Minn Med 94:44-47
8. Ptaszek LM, Mansour M, Ruskin JN, Chien KR (2012) Towards regenerative therapy for cardiac disease. Lancet 379:933-942
9. Leri A, Kajstura J, Anversa P (2011) Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res 109:941-961
10. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98-102
11. Kajstura J, Bai Y, Cappetta D, Kim J, Arranto C, Sanada F, D'Amario D, Matsuda A, Bardelli S, Ferreira-Martins J, Hosoda T, Leri A, Rota M, Loscalzo J, Anversa P (2012) Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res 111(7):894-906
12. Dimmeler S, Zeiher AM, Schneider MD (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115:572-583
13. Malliaras K, Marban E (2011) Cardiac cell therapy: where we’ve been, where we are, and where we should be headed. Br Med Bull 98:161-185
14. Bartunek J, Vanderheyden M, Hill J, Terzic A (2010) Cells as biologics for cardiac repair in ischaemic heart failure. Heart 96:792-800
15. Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473:326-335
16. Loffredo FS, Steinhauser ML, Gannon J, Lee RT (2011) Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8:389-398
17. Behfar A, Crespo-Diaz R, Nelson TJ, Terzic A, Gersh BJ (2010) Stem cells: clinical trials results the end of the beginning or the beginning of the end? Cardiovasc Hematol Disord Drug Targets 10:186-201
18. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A (2009) Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc 84:876-892
19. Bartunek J, Sherman W, Vanderheyden M, Fernandez-Aviles F, Wijns W, Terzic A (2009) Delivery of biologics in cardiovascular regenerative medicine. Clin Pharmacol Ther 85:548-552
20. Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernandez-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, Itescu S, Miller LW, Dinsmore JH, Dangas GD, Popma JJ, Hall JL, Holmes DR Jr (2010)Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv 3:265-275
21. Psaltis PJ, Zannettino AC, Gronthos S, Worthley SG (2010) Intramyocardial navigation and mapping for stem cell delivery. J Cardiovasc Transl Res 3:135-146
22. Passier R, van Laake LW, Mummery CL (2008) Stem-cell-based therapy and lessons from the heart. Nature 453:322-329
23. Hansson EM, Lindsay ME, Chien KR (2009) Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 5:364-377
24. Segers VF, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451:937-942
25. Steinhauser ML, Lee RT (2011) Regeneration of the heart. EMBO Mol Med 3:701-712
26. Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A (2009) Stem cell platforms for regenerative medicine. Clin Transl Sci 2:222-227
27. Nelson T, Behfar A, Terzic A (2008) Stem cells: biologics for regeneration. Clin Pharmacol Ther 84:620-623
28. European Medicinal Agency (2011) Reflection paper on stem cell-based medicinal products. EMA/CAT/571134/2009:1-14
29. Murry CE, Field LJ, Menasché P (2005) Cell-based cardiac repair: reflections at the 10-year point. Circulation 112:3174-3183
30. Nelson TJ, Martinez-Fernandez A, Terzic A (2010) Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol 7:700-710
31. Mummery CL, Davis RP, Krieger JE (2010) Challenges in using stem cells for cardiac repair. Sci Transl Med 2:27 ps 17
32. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B, Dardas T, Mignone JL, Izawa A, Hanna R, Viswanathan M, Gold JD, Kotlikoff MI, Sarvazyan N, Kay MW, Murry CE, Laflamme MA (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489:322-325
33. Daley GQ (2012) The promise and perils of stem cell therapeutics. Cell Stem Cell 10:740-749
34. Nelson TJ, Terzic A (2011) Induced pluripotent stem cells: an emerging theranostics platform. Clin Pharmacol Ther 89:648-650
35. Mummery C (2011) Induced pluripotent stem cells—a cautionary note. N Engl J Med 364:2160-2162
36. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-386
37. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485:593-598
38. Chen JX, Krane M, Deutsch MA, Wang L, Rav-Acha M, Gregoire S, Engels MC, Rajarajan K, Karra R, Abel ED, Wu JC, Milan D, Wu SM (2012) Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res 110:50-55
39. Song K, Nam Y-J, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN (2012) Heart repair by reprogramming nonmyocytes with cardiac transcription factors. Nature 485:599-604
40. Sun N, Longaker MT, Wu JC (2010) Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle 9:880-885
41. Janssens S (2010) Stem cells in the treatment of heart disease. Annu Rev Med 61:287-300
42. Menasche P (2011) Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 50:258-265
43. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189-1200
44. Duckers HJ, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A, Bartunek J, Nienaber C, Macaya C, Peters N, Smits P, Siminiak T, van Mieghem W, Legrand V, Serruys PW (2011) Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention 6:805-812
45. Wollert KC, Drexler H (2010) Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 7:204-205
46. Bartunek J, Behfar A, Vanderheyden M, Wijns W, Terzic A (2008) Mesenchymal stem cells and cardiac repair: principles and practice. J Cardiovasc Transl Res 1:115-119
47. Williams AR, Hare JM (2011) Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109:923-940
48. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167:989-997
49. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM (2008) Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29:1807-18018
50. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210-1221
51. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148
52. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grogaard HK, Bjornerheim R, Brekke M, Muller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med355:1199-1209
53. Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S (2007) Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28:766-772
54. Malliaras K, Kreke M, Marban E (2011) The stuttering progress of cell therapy for heart disease. Clin Pharmacol Ther 90:532-541
55. Lovell MJ, Mathur A (2010) Cardiac stem cell therapy: progress from the bench to bedside. Heart 96:1531-1537
56. Penn MS, Dong F, Klein S, Mayorga ME (2011) Stem cells for myocardial regeneration. Clin Pharmacol Ther 90:499-501
57. Strauer BE, Steinhoff G (2011) 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol 58:1095-1104
58. van Ramshorst J, Rodrigo SF, Schalij MJ, Beeres SL, Bax JJ, Atsma DE (2011) Bone marrow cell injection for chronic myocardial ischemia: the past and the future. J Cardiovasc Transl Res 4:182-191
59. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN) (2012) Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307:1717-1726
60. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E (2012) Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2:CD006536
61. Yoon CH, Koyanagi M, Iekushi K, Seeger F, Urbich C, Zeiher AM, Dimmeler S (2010) Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment. Circulation 121:2001-2011
62. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847-1857
63. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marban L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marban E (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379:895-904
64. Behfar A, Terzic A (2006) Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat Clin Pract Cardiovasc Med 3(suppl 1):S78-S82
65. Marban E, Malliaras K (2010) Boot camp for mesenchymal stem cells. J Am Coll Cardiol 56:735-737
66. Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A (2008) Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol 45:523-529
67. Mercola M, Ruiz-Lozano P, Schneider MD (2011) Cardiac muscle regeneration: lessons from development. Genes Dev 25:299-309
68. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A (2010) Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 56:721-734
69. Waldman SA, Terzic A (2012) Knowledge cycle transforms therapeutic innovation. Clin Pharmacol Ther 91:3-8
70. Waldman SA, Terzic A (2011) Patient-centric clinical pharmacology advances the path to personalized medicine. Biomark Med 5:697-700
71. Chavakis E, Koyanagi M, Dimmeler S (2010) Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation 121:325-335
72. Mohsin S, Siddiqi S, Collins B, Sussman MA (2011) Empowering adult stem cells for myocardial regeneration. Circ Res 109:1415-1428
73. Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 50:280-289
74. Nelson TJ, Behfar A, Terzic A (2009) Regenerative medicine and stem cell therapeutics. In: Waldman SA, Terzic A (eds) Pharmacology and therapeutics: principles to practice (pp 1317-1331). Saunders, Philadelphia, PA
75. Vunjak-Novakovic G, Lui KO, Tandon N, Chien KR (2011) Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng 13:245-267
76. Godier-Furnemont AF, Martens TP, Koeckert MS, Wan L, Parks J, Arai K, Zhang G, Hudson B, Homma S, Vunjak-Novakovic G (2011) Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci USA 108:7974-7979
77. Singelyn JM, Sundaramurthy P, Johnson TD, Schup-Magoffin PJ, Hu DP, Faulk DM, Wang J, Mayle KM, Bartels K, Salvatore M, Kinsey AM, Demaria AN, Dib N, Christman KL (2012) Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol 59:751-763
78. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA (2008) Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 14:213-221
79. Song JJ, Ott HC (2011) Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 17:424-432
80. Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP (2011) Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol 33:307-315